SALL4 and lung cancer: Then, we also evaluated the survival outcome of all lung cancer cases by Kaplan–Meier survival analysis indicated that SALL4-high NSCLCs had lower overall and recurrence-free ten-year survival ratio in comparison to that of SALL4-low NSCLCs from the PrognoScan database (Fig. 1d, e).